Who is sponsoring NCT02798653?

NCT02798653 is sponsored by Royan Institute.

What condition does NCT02798653 study?

NCT02798653 studies Infertility.

What drugs are being tested in NCT02798653?

Interventions: Choriomon® injection, Choriomon® injection+Endometrin ®, Endometrin ® vaginal tablets.

What is the status of NCT02798653?

NCT02798653 is currently UNKNOWN.

Last reviewed 2018-12-26 · How we verify

Comparison of Different Methods for Luteal Phase Support in IVF / ICSI Cycles With Antagonist Protocol in Women With Poor Ovarian Response

NCT02798653 Phase 3 UNKNOWN

This study is a randomized clinical trial to investigate the efficacy of different luteal phase support methods in patients with poor ovarian response undergoing IVF and intracytoplasmic sperm injection (ICSI) cycles. The study protocol is approved by the Ethics Committee (Institutional Review Board) of Royan institute. The study is conducted according to the Declaration of Helsinki for medical research. All participants provide informed consent after counseling for infertility treatments and routine IVF/ICSI programs.

Details

Lead sponsor	Royan Institute
Phase	Phase 3
Status	UNKNOWN
Enrolment	210
Start date	2015-11
Completion	2019-12

Conditions

Infertility

Interventions

Choriomon® injection
Choriomon® injection+Endometrin ®
Endometrin ® vaginal tablets

Primary outcomes

Clinical pregnancy rate — 4 weeks
Evaluation the clinical pregnancy rate at least 4 weeks after embryo transfer.

Countries

Iran